Our data suggested that TyG performed better than ALT to discriminate NAFLD as indicated by the present study that the TyG had a stronger association with risk of NAFLD and a larger AUC for diagnosing NAFLD, as compared with ALT. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.